Involvement of clathrin and AP-2 in the trafficking of MHC class II molecules to antigen-processing compartments

  1. Peter J. McCormick,
  2. José A. Martina*, and
  3. Juan S. Bonifacino
  1. Cell Biology and Metabolism Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892
  1. Edited by Peter Cresswell, Yale University School of Medicine, New Haven, CT, and approved April 21, 2005 (received for review March 17, 2005)

Abstract

Major histocompatibility complex class II (MHC-II) molecules are composed of two polymorphic chains, α and β, which assemble with an invariant chain, Ii, in the endoplasmic reticulum. The assembled MHC-II complexes are transported to the Golgi complex and then to late endosomes/lysosomes, where Ii is degraded and αβ dimers bind peptides derived from exogenous antigens. Targeting of MHC-II molecules to these compartments is mediated by two dileucine-based signals in the cytoplasmic domain of Ii. These signals bind in vitro to two adaptor protein (AP) complexes, AP-1 and AP-2, which are components of clathrin coats involved in vesicle formation and cargo sorting. The physiological roles of these proteins in MHC-II molecule trafficking, however, remain to be addressed. Here, we report the use of RNA interference to examine the involvement of clathrin and four AP complexes (AP-1, AP-2, AP-3, and AP-4) in MHC-II molecule trafficking in vivo. We found that depletion of clathrin or AP-2 caused >10-fold increases in Ii expression on the cell surface and a concomitant decrease in Ii localization to endosomal/lysosomal vesicles. In addition, depletion of clathrin or AP-2 delayed the degradation of Ii and reduced the surface expression of peptide-loaded αβ dimers. In contrast, depletion of AP-1, AP-3, or AP-4 had little or no effect. These findings demonstrate that clathrin and AP-2 participate in MHC-II molecule trafficking in vivo. Because AP-2 is only associated with the plasma membrane, these results also indicate that a significant pool of MHC-II molecules traffic to the endosomal–lysosomal system by means of the cell surface.

Footnotes

  • To whom correspondence should be addressed at: Cell Biology and Metabolism Branch, National Institute of Child Health and Human Development, Building 18T, Room 101, National Institutes of Health, Bethesda, MD 20892. E-mail: bonifacinoj{at}mail.nih.gov.

  • * Present address: Laboratory of Cell Biology, National Heart, Lung, and Blood Institute, Building 50, Room 2308, National Institutes of Health, Bethesda, MD 20892.

  • Author contributions: P.J.M. and J.S.B. designed research; P.J.M. and J.A.M. performed research; P.J.M., J.A.M., and J.S.B. analyzed data; and P.J.M. and J.S.B. wrote the paper.

  • This paper was submitted directly (Track II) to the PNAS office.

  • Abbreviations: MHC-II, MHC class II; MHC-I, MHC class I; AP, adaptor protein; TfR, transferrin receptor; TGN, trans-Golgi network; Ii, invariant chain; CHC, clathrin heavy chain; siRNA, small interfering RNA.

  • Note Added in Proof. An article by Dugast et al. (44) showing similar findings is in press.

  • Freely available online through the PNAS open access option.

« Previous | Next Article »Table of Contents